Diluting women's share in marital property in the event of divorce, the government has sought to restrict the provision for `immoveable property' to residential assets, a move opposed by women's rights activists. The marriage amendment bill seeks to amend the Hindu Marriage Act, 1955, and the Special Marriage Act, 1954, legislating a women's right to marital property acquired during the subsistence of marriage. The amendment cleared by the Union Cabinet recently...

Health activists and cancer patients in the US have pounced on Swiss drug multinational Novartis for the high price of its famous, multi-billion dollar anti-cancer drug Glivec, a development which challenges pharma MNCs' claims of cheap access and affordability for patented drugs. Such protests, which began first in Europe, and have now spread to the US, could make it more difficult for pharma MNCs in developing countries to convince sceptical governments...

A government panel has recommended the enactment of a “comprehensive, standalone law” on the so-called “honour killings”, handing equal punishment to the killers, plotters and the instigators at kangaroo Courts. “The current provisions in the Indian Penal Code are inadequate in dealing with these acts of crime,” says the Planning Commission’s steering committee on women’s agency and child rights for the 12th Five-Year Plan. Its report, posted on the plan panel’s website...

-The Indian Express After retrospective taxes, here comes the retroactive cartoon The no-no cartoon was published in Shankar’s Weekly on August 28, 1949 and reproduced in many Shankar collections, including one with a Nehru quote as title that will make his party men squirm today — “Don’t spare me Shankar”. The Congress government has pulled out the cartoon and the textbook that carried it. The cartoon features Nehru himself, standing behind a...

Having watched from the ringside for many years now, I have no doubt in advising that the steering wheel must be firmly grasped by the government and direction given to policies that should be stable for at least the medium term. This is crucial for the growth of Indian pharma, a $20-billion industry growing at an average of 12% considering both domestic and export arenas. Price control: The biggest and most...